The Christie NHS Foundation Trust, Manchester, UK
Mon 02 12:40
Understanding Metyrapone in Cushing's Syndrome: Mechanism of action and rationale for chronotherapy
The Christie NHS Foundation Trust, Manchester, UK
Birmingham, UK
Mon 02 12:35
What Do the New ESE Guidelines for Hypoparathyroidism Mean for Me and My Patients?
Birmingham, UK
Oxford, UK
Mon 02 12:25
The Burden and Consequences of Hypoparathyroidism
Oxford, UK
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 02 12:55
Clinical use of Metyrapone Chronotherapy: Patient selection, safety management and clinical integration
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Queen Elizabeth Hospital, Birmingham, UK
Mon 02 12:25
When to suspect Cushing's early: Early clues and diagnostic challenges
Queen Elizabeth Hospital, Birmingham, UK
Glasgow , UK
Mon 02
Yorvipath® (palopegteriparatide) From Evidence to Real World Application
Glasgow , UK
Oxford University Hospital, United Kingdom
Mon 02 12:20
Opening Remarks & Introduction
Oxford University Hospital, United Kingdom
Mon 02 13:10
Q&A and closing
Oxford University Hospital, United Kingdom
Wed 04 12:30
Welcome and introduction
Oxford University Hospital, United Kingdom
Wed 04 13:25
0 result(s) found.